Lu, S., Wu, J. (2025). Reply to: Concerns on Potential Risk of Roxadustat in Promoting Tumor Progression: Double-Edged Sword of Hypoxia-Inducible Factor-1α Activation. Journal of Clinical Oncology. https://doi.org/10.1200/jco-24-02684